The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Nomenclature for Macrolide and Macrolide-Lincosamide-Streptogramin B Resistance Determinants
Open accessAbstract
Macrolides are composed of 14 (erythromycin and clarithromycin)-, 15 (azithromycin)-, or 16 (josamycin, spiramycin, and tylosin)-membered lactones to which are attached amino and/or neutral sugars via glycosidic bonds. Erythromycin was introduced in 1952 as the first macrolide antibiotic. Unfortunately, within a year, erythromycin-resistant (Emr) staphylococci from the United States, Europe, and Japan were described (101). Erythromycin is produced by Saccharopolyspora erythraea, while the newer macrolides are semisynthetic molecules with substitutions on the lactone. The newer derivatives, such as clarithromycin and azithromycin, have improved intracellular and tissue penetration, are more stable, are better absorbed, have a lower incidence of gastrointestinal side effects, and are less likely to interact with other drugs. They are useable against a wider range of infectious bacteria, such as Legionella, Chlamydia, Haemophilus, and some Mycobacterium species (not M. tuberculosis), and their pharmacokinetics provide for less frequent dosing than erythromycin (21, 47, 96, 97). As a result, the usage of the newer macrolides has increased dramatically over the last few years, which has led to increased exposure of bacterial populations to macrolides (101–103, 107). Macrolides inhibit protein synthesis by stimulating dissociation of the peptidyl-tRNA molecule from the ribosomes during elongation (101, 103). This results in chain termination and a reversible stoppage of protein synthesis. The first mechanism of macrolide resistance described was due to posttranscriptional modification of the 23S rRNA by the adenine-N6 methyltransferase (101–103). These enzymes add one or two methyl groups to a single adenine (A2058 in Escherichia coli) in the 23S rRNA moiety. Over the last 30 years, a number of adenine-N6-methyltransferases from different species, genera, and isolates have been described. In general, genes encoding these methylases have been designated erm (erythromycin ribosome methylation), although there are exceptions, especially in the antibiotic-producing organisms (see Tables Tables11 and and3)3) (103). As the number of erm genes described has grown, the nomenclature for these genes has varied and has been inconsistent (Table (Table1).1). In some cases, unrelated genes have been given the same letter designation, while in other cases, highly related genes (>90% identity) have been given different names. TABLE 1 rRNA methylase genes involved in MLSB resistance TABLE 3 Location of antibiotic resistance genesa The binding site in the 50S ribosomal subunit for erythromycin overlaps the binding site of the newer macrolides, as well as the structurally unrelated lincosamides and streptogramin B antibiotics. The modification by methylase(s) reduces the binding of all three classes of antibiotics, which results in resistance against macrolides, lincosamides, and streptogramin B antibiotics (MLSB). The rRNA methylases are the best studied among macrolide resistance mechanisms (47, 101–103). However, a variety of other mechanisms have been described which also confer resistance (Table (Table2).2). Many of these alternative mechanisms of resistance confer resistance to only one or two of the antibiotic classes of the MLSB complex. TABLE 2 Efflux and inactivating genes In this review, we suggest a new nomenclature for naming MLS genes and propose to use the rules developed for identifying and naming new tetracycline resistance genes (51, 52). This system, with a few recent modifications, was originally designed because of the ability of two genes to be distinguished uniquely by DNA-DNA probe methodology (51). It was generally found that two genes with <80% amino acid sequence identity provided enough variability in nucleotide sequence to permit distinct probes to be designed. Although many investigators are likely to sequence new genes, the use of probe technology allows rapid identification of isolates containing potentially new genes, as well as a reliable way to screen populations and determine the frequency of any one resistant determinant. Therefore, we continued this paradigm by assigning two genes of ≥80% amino acid identity to the same class and same letter designation, while two genes that show ≤79% amino acid identity are given a different letter designation. Table Table11 shows the results of the classification, with some classes having members with little variability, while others, like classes A and O, show a greater range of homology at both the DNA and amino acid levels. As new gene sequences emerge, ideally they will need to be compared by oligonucleotide probe hybridization and/or sequence analysis against the bank of known genes before a new designation is assigned. If multiple genes are available in any one class, especially when there is a range as in class A, then all representative members of the class should be examined, not just one.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2019) · ASM Press eBooks · doi:10.1128/9781683670131 · Cited by 1,009
Erythromycin resistance by ribosome modification
Weisblum, B. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.577 · Cited by 1,008
Detection of erythromycin-resistant determinants by PCR
Sutcliffe, J., Grebe, T., Tait-Kamradt, A., & Wondrack, L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2562 · Cited by 989
Self-citationBacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification
Leclercq, R., & Courvalin, P. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1267 · Cited by 628
Self-citationKatz, E., Thompson, C. J., & Hopwood, D. A. (1983) · Microbiology · doi:10.1099/00221287-129-9-2703 · Cited by 628
Sutcliffe, J., Tait-Kamradt, A., & Wondrack, L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1817 · Cited by 619
Self-citationConjugative transposons: an unusual and diverse set of integrated gene transfer elements
Salyers, A. A., Shoemaker, N. B., Stevens, A. M., & Li, L. Y. (1995) · Microbiological Reviews · doi:10.1128/mmbr.59.4.579-590.1995 · Cited by 423
Unconstrained bacterial promiscuity: the Tn916–Tn1545 family of conjugative transposons
Clewell, D. B., Flannagan, S. E., Jaworski, D. D., & Clewell, D. B. (1995) · Trends in Microbiology · doi:10.1016/s0966-842x(00)88930-1 · Cited by 391
Clancy, J., Petitpas, J., Dib‐Hajj, F., Yuan, W., Cronan, M., Kamath, A. V., Bergeron, J., & Retsema, J. A. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.01521.x · Cited by 358
mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae
Tait-Kamradt, A., Clancy, J., Cronan, M., Dib-Hajj, F., Wondrack, L., Yuan, W., & Sutcliffe, J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2251 · Cited by 298
Self-citation
Cited by
Acquired Antibiotic Resistance Genes: An Overview
van Hoek, A. H. A. M., Mevius, D., Guerra, B., Mullany, P., Roberts, A. P., & Aarts, H. J. M. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00203 · Cited by 1,136
Leclercq, R. (2002) · Clinical Infectious Diseases · doi:10.1086/324626 · Cited by 1,102
Efflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
Antibiotic resistance genes in water environment
Zhang, X.-X., Zhang, T., & Fang, H. H. P. (2009) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-008-1829-z · Cited by 998
The use of bacterial spore formers as probiotics: Table 1
Hong, H. A., Duc, L. H., & Cutting, S. M. (2005) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.12.001 · Cited by 975
Antibiotic resistance in Staphylococcus aureus. Current status and future prospects
Foster, T. J. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux007 · Cited by 845
Molecular basis of bacterial resistance to chloramphenicol and florfenicol
Schwarz, S., Kehrenberg, C., Doublet, B., & Cloeckaert, A. (2004) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.04.001 · Cited by 800
Antibiotic resistance in food lactic acid bacteria—a review
Mathur, S., & Singh, R. (2005) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2005.03.008 · Cited by 754
“…classes share the same target site, and this target site is modified by the product of a resistance gene, cross-resistance between structurally unrelated antibiotics is observed; e.g. combined resistance to macrolides, lincosamides and streptogramin B by the erm genes (Roberts et al., 1999).”
BackgroundButaye, P., Devriese, L. A., & Haesebrouck, F. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.2.175-188.2003 · Cited by 712
Long, K. S., Poehlsgaard, J., Kehrenberg, C., Schwarz, S., & Vester, B. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00131-06 · Cited by 708
Antibacterial Natural Products in Medicinal Chemistry—Exodus or Revival?
von Nussbaum, F., Brands, M., Hinzen, B., Weigand, S., & Häbich, D. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600350 · Cited by 672
Nash, K. A., Brown-Elliott, B. A., & Wallace, R. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01275-08 · Cited by 638
Efflux pumps as antimicrobial resistance mechanisms
Poole, K. (2007) · Annals of Medicine · doi:10.1080/07853890701195262 · Cited by 562
Macrolide Resistance Conferred by Base Substitutions in 23S rRNA
Vester, B., & Douthwaite, S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.1-12.2001 · Cited by 556
Brown-Elliott, B. A., Nash, K. A., & Wallace, R. J. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05030-11 · Cited by 541
Doern, G. V., Heilmann, K. P., Huynh, H. K., Rhomberg, P. R., Coffman, S. L., & Brueggemann, A. B. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1721-1729.2001 · Cited by 538
Shoemaker, N. B., Vlamakis, H., Hayes, K., & Salyers, A. A. (2001) · Applied and Environmental Microbiology · doi:10.1128/aem.67.2.561-568.2001 · Cited by 529
Molecular Detection of Antimicrobial Resistance
Fluit, A. C., Visser, M. R., & Schmitz, F.-J. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.836-871.2001 · Cited by 525
The macrolide antibiotic renaissance
Dinos, G. P. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13936 · Cited by 471
Fiebelkorn, K. R., Crawford, S. A., McElmeel, M. L., & Jorgensen, J. H. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.10.4740-4744.2003 · Cited by 454
Editorial: Assessing the antimicrobial susceptibility of bacteria obtained from animals
Schwarz, S., Silley, P., Simjee, S., Woodford, N., van Duijkeren, E., Johnson, A. P., & Gaastra, W. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq037 · Cited by 442
Roberts, M. C. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01145.x · Cited by 392
Self-citationScreening for Bacillus Isolates in the Broiler Gastrointestinal Tract
Barbosa, T. M., Serra, C. R., La Ragione, R. M., Woodward, M. J., & Henriques, A. O. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.2.968-978.2005 · Cited by 372
Use of antimicrobials in veterinary medicine and mechanisms of resistance
Schwarz, S., & Chaslus-Dancla, E. (2001) · Veterinary Research · doi:10.1051/vetres:2001120 · Cited by 370
Novel Macrolide-Specific ABC-Type Efflux Transporter in Escherichia coli
Kobayashi, N., Nishino, K., & Yamaguchi, A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.19.5639-5644.2001 · Cited by 353
Analysis of antibiotic resistance regions in Gram-negative bacteria
Partridge, S. R. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00277.x · Cited by 344
Toh, S., Xiong, L., Arias, C. A., Villegas, M. V., Lolans, K., Quinn, J., & Mankin, A. S. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05744.x · Cited by 338
“Often associated with mobile genetic elements, natural resistance genes can rapidly spread among pathogenic strains and impede the clinical value of many important drugs (Roberts et al., 1999; Bozdogan et al., 2004; Robicsek et al., 2006; Reyes et al., 2007).”
BackgroundKehrenberg, C., Schwarz, S., Jacobsen, L., Hansen, L. H., & Vester, B. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04754.x · Cited by 333
Genetic Diversity among Enterococcus faecalis
McBride, S. M., Fischetti, V. A., LeBlanc, D. J., Moellering, R. C., & Gilmore, M. S. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000582 · Cited by 330
Macrolide Resistance Among Invasive <EMPH TYPE="ITAL">Streptococcus pneumoniae</EMPH> Isolates
Hyde, T. B. (2001) · JAMA · doi:10.1001/jama.286.15.1857 · Cited by 315
Lewis, J. S., & Jorgensen, J. H. (2005) · Clinical Infectious Diseases · doi:10.1086/426894 · Cited by 313
Horizontal gene transfer and the genomics of enterococcal antibiotic resistance
Palmer, K. L., Kos, V. N., & Gilmore, M. S. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.08.004 · Cited by 312
Review of Macrolides and Ketolides: Focus on Respiratory Tract Infections
Zhanel, G. G., Dueck, M., Hoban, D. J., Vercaigne, L. M., Embil, J. M., Gin, A. S., & Karlowsky, J. A. (2001) · Drugs · doi:10.2165/00003495-200161040-00003 · Cited by 304
Tait-Kamradt, A., Davies, T., Cronan, M., Jacobs, M. R., Appelbaum, P. C., & Sutcliffe, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2118-2125.2000 · Cited by 281
Self-citationResistance to Macrolides and Related Antibiotics in Streptococcus pneumoniae
Leclercq, R., & Courvalin, P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2727-2734.2002 · Cited by 269
Self-citationAntimicrobial Resistance in Enterococcus spp. of animal origin
Torres, C., Alonso, C. A., Ruiz-Ripa, L., León-Sampedro, R., Del Campo, R., & Coque, T. M. (2018) · Microbiology Spectrum · doi:10.1128/microbiolspec.arba-0032-2018 · Cited by 262
Chen, J., Yu, Z., Michel, F. C., Wittum, T., & Morrison, M. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.02799-06 · Cited by 261
Occurrence and spread of antibiotic resistances in Enterococcus faecium
Klare, I., Konstabel, C., Badstübner, D., Werner, G., & Witte, W. (2003) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(03)00190-9 · Cited by 260
Tait-Kamradt, A., Davies, T., Appelbaum, P. C., Depardieu, F., Courvalin, P., Petitpas, J., Wondrack, L., Walker, A., Jacobs, M. R., & Sutcliffe, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3395-3401.2000 · Cited by 260
Self-citationTranslation and Protein Synthesis: Macrolides
Katz, L., & Ashley, G. W. (2005) · Chemical Reviews · doi:10.1021/cr030107f · Cited by 177
Adimpong, D. B., Sørensen, K. I., Thorsen, L., Stuer-Lauridsen, B., Abdelgadir, W. S., Nielsen, D. S., Derkx, P. M. F., & Jespersen, L. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.00730-12 · Cited by 155
Choi, J., Rieke, E. L., Moorman, T. B., Soupir, M. L., Allen, H. K., Smith, S. D., & Howe, A. (2018) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiy006 · Cited by 19
Metadata
- Authors
- Roberts, M. C., Sutcliffe, J., Courvalin, P., Jensen, L. B., Rood, J., & Seppala, H.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1999-12
- Volume
- 43
- Issue
- 12
- Pages
- 2823-2830
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2171076011
- Cited by
- 874
- References
- 78
- FWCI
- 20.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.